首页 › 癌症（所有类型） › 得克萨斯州 › Irving
Irving TX 癌症（所有类型）临床试验
15项针对 癌症（所有类型）的研究正在 Irving及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
招募中1 期
- NEXT Dallas, Irving
Registry Study for Radiation Therapy Outcomes
招募中观察性研究
- Texas Center for Proton Therapy, Irving
REC-7735 in Participants With Solid Tumors
招募中1/2 期
- NEXT Oncology - Dallas, Irving
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
招募中3 期
- US Oncology Research Investigational Products Center, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- NEXT Dallas, Irving
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
招募中1 期
- NEXT Oncology ( Site 0051), Irving
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
招募中1/2 期
- NEXT Oncology ( Site 1012), Irving
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- NEXT Oncology Dallas, Irving
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
招募中1 期
- NEXT Oncology Dallas, Irving
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Dallas, Irving
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Dallas, Irving
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
招募中1/2 期
- NEXT Oncology, Irving
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
招募中1 期
- NEXT Oncology, Irving
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
招募中1/2 期
- NEXT Dallas, Irving
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
招募中观察性研究
- Texas Center for Proton Therapy, Irving
其他城市的 癌症（所有类型）试验
- Houston, TX122 项研究
- New York City, NY110 项研究
- Boston, MA86 项研究
- Los Angeles, CA73 项研究
- Nashville, TN65 项研究
- Washington, DC60 项研究
- Philadelphia, PA60 项研究
- Durham, NC59 项研究
- Chicago, IL52 项研究
- Seattle, WA50 项研究
- Atlanta, GA50 项研究
- Arlington, VA48 项研究
Irving的其他研究
- 非小细胞肺癌22 项研究
- 结直肠癌13 项研究
- 转移性癌症11 项研究
- 胰腺癌7 项研究
- 胃癌7 项研究
- 头颈鳞状细胞癌6 项研究
- 肺癌6 项研究
- 小细胞肺癌6 项研究
- 乳腺癌6 项研究
- 卵巢癌5 项研究
- 三阴性乳腺癌4 项研究
- 食管癌4 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。